Page 122 - 《中国药房》2023年9期
P. 122

tice  guidelines  for  therapeutic  drug  monitoring  of  teico‐  for  Anti-infective  Pharmacology (ISAP),Society  of
               planin:a  consensus  review  by  the  Japanese  Society  of   Critical Care Medicine (SCCM),and Society of Infectious
               Chemotherapy  and  the  Japanese  Society  of  Therapeutic   Diseases Pharmacists (SIDP)[J]. Pharmacotherapy,2019,
               Drug  Monitoring[J].  J  Antimicrob  Chemother,2022,77  39(1):10-39.
              (4):869-879.                                    [19]  中国医药教育协会感染疾病专业委员会,中华医学会呼
          [ 9 ]  BALBI H J. Chloramphenicol:a review[J]. Pediatr Rev,  吸病学分会,中华医学会重症医学分会,等. 中国多黏菌
               2004,25(8):284-288.                                 素类抗菌药物临床合理应用多学科专家共识[J]. 中华结
          [10]  RAO G G,KONICKI R,CATTANEO D,et al. Therapeu‐      核和呼吸杂志,2021,44(4):292-310.
               tic  drug  monitoring  can  improve  linezolid  dosing  regi‐  [20]  JOHN  J,LOO  A,MAZUR  S,et  al.  Therapeutic  drug
               mens  in  current  clinical  practice:a  review  of  linezolid   monitoring of systemic antifungal agents:a pragmatic ap‐
               pharmacokinetics  and  pharmacodynamics[J].  Ther  Drug   proach  for  adult  and  pediatric  patients[J].  Expert  Opin
               Monit,2020,42(1):83-92.                             Drug Metab Toxicol,2019,15(11):881-895.
          [11]  Agence  française  de  sécurité  sanitaire  des  produits  de   [21]  ASHBEE  H  R,BARNES  R  A,JOHNSON  E  M,et  al.
               santé. Update on good use of injectable aminoglycosides,  Therapeutic  drug  monitoring  (TDM)  of  antifungal
               gentamycin,tobramycin,netilmycin,amikacin. Pharmaco‐  agents:guidelines  from  the  British  Society  for  Medical
               logical  properties,indications,dosage,and  mode  of          Mycology[J].  J  Antimicrob  Chemother,2014,69(5):
               administration,treatment monitoring[J]. Med Mal Infect,  1162-1176.
               2012,42(7):301-308.                            [22]  CHEN  K,ZHANG  X  L,KE  X  Y,et  al.  Individualized
          [12]  SA  Health. Aminoglycosides:recommendations  for  use,  medication  of  voriconazole:a  practice  guideline  of  the
               dosing and monitoring[EB/OL].[2023-02-10]. http://www.  division of therapeutic drug monitoring,Chinese Pharma‐
               sahealth.sa.gov.au/antimicrobials.                  cological  Society[J].  Ther  Drug  Monit,2018,40(6):
          [13]  TRÖGER U,DRUST A,MARTENS-LOBENHOFFER J,            663-674.
               et al. Decreased meropenem levels in intensive care unit   [23]  泊沙康唑临床应用专家组. 泊沙康唑临床应用专家共识
               patients with augmented renal clearance:benefit of thera‐  [J]. 国际呼吸杂志,2020,40(4):241-261.
               peutic drug monitoring[J]. Int J Antimicrob Agents,2012,  [24]  焦正,李新刚,尚德为,等. 模型引导的精准用药:中国专
               40(4):370-372.                                      家共识:2021 版[J]. 中国临床药理学与治疗学,2021,26
          [14]  周华,姚亚克,俞云松,等. 重症患者耐药阴性菌抗菌治                        (11):1215-1228.
               疗:药代动力学/药效动力学指导的个体化[J]. 中华内科                   [25]  郭琦,周伟燕,张天娇,等. 治疗药物监测样本检测质量
               杂志,2017,56(5):340-343.                              现状和标准化构想[J]. 中华检验医学杂志,2021,44(8):
          [15]  YOSHIZAWA K,IKAWA K,IKEDA K,et al. Population      674-678.
               pharmacokinetic-pharmacodynamic   target   attainment   [26]  ABDULLA A,EDWINA E E,FLINT R B,et al. Model-
               analysis  of  imipenem  plasma  and  urine  data  in  neonates   informed  precision  dosing  of  antibiotics  in  pediatric
               and children[J]. Pediatr Infect Dis J,2013,32(11):1208-  patients:a  narrative  review[J].  Front  Pediatr,2021,9:
               1216.                                               624639.
          [16]  ZHAO H H,TANG W J,YANG Y X,et al. PK/PD study   [27]  USTER D W,STOCKER S L,CARLAND J E,et al. A
               of tigecycline in severely infected patients with continuous   model averaging/selection approach improves the predic‐
               renal replacement therapy[J]. Int J Clin Pharmacol Ther,  tive  performance  of  model-informed  precision  dosing:
               2020,58(10):531-538.                                vancomycin  as  a  case  study[J].  Clin  Pharmacol  Ther,
          [17]  FAN G J,JIN L,BAI H S,et al. Safety and efficacy of      2021,109(1):175-183.
               tigecycline in intensive care unit patients based on thera‐  [28]  WANG J,XU H,LI R,et al. Model-oriented dose optimi‐
               peutic drug monitoring[J]. Ther Drug Monit,2020,42(6):  zation of voriconazole in critically ill children[J]. Antimi‐
               835-840.                                            crob Agents Chemother,2021,65(9):e0049321.
          [18]  TSUJI B T,POGUE J M,ZAVASCKI A P,et al. Interna‐  [29]  曾云,冯大飞,张磊,等. 线粒体MT-RNR1基因突变与药
               tional consensus guidelines for the optimal use of the poly‐  物 性 聋 [J].  听 力 学 及 言 语 疾 病 杂 志 ,2013,21(4):
               myxins:endorsed  by  the  American  College  of  Clinical   428-430.
               Pharmacy (ACCP),European Society of Clinical Micro‐          (收稿日期:2022-09-28  修回日期:2023-03-13)
               biology  and  Infectious  Diseases (ESCMID),Infectious                             (编辑:刘明伟)
               Diseases Society of America (IDSA),International Society





          · 1136 ·    China Pharmacy  2023 Vol. 34  No. 9                              中国药房  2023年第34卷第9期
   117   118   119   120   121   122   123   124   125   126   127